ICD-10 Coding for Hyperuricemia(E79.0, E79.0B, E79.0H)
Explore detailed ICD-10 coding guidelines for hyperuricemia, including documentation requirements, common pitfalls, and billing considerations.
Complete code families applicable to Hyperuricemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E79.0 | Hyperuricemia without signs of inflammatory arthritis and tophaceous disease | Use when hyperuricemia is documented without symptoms of gout or tophi. |
|
| E79.2 | Hyperuricemia with inflammatory arthritis | Use when hyperuricemia is accompanied by symptoms of inflammatory arthritis. |
|
| E79.4 | Asymptomatic hyperuricemia | Use when hyperuricemia is documented without any symptoms. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHyperuricemia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hyperuricemia.
Failing to document absence of symptoms
Impact
Clinical: Misdiagnosis of asymptomatic conditions, Regulatory: Non-compliance with documentation standards, Financial: Potential reimbursement issues
Mitigation
Ensure thorough patient history, Confirm absence of symptoms in documentation
Coding hyperuricemia as gout without confirmation
Impact
Reimbursement: Potential claim denials for incorrect coding, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation
Ensure synovial fluid analysis confirms gout before coding.
Documentation of asymptomatic status
Impact
Failure to document asymptomatic status can lead to audit issues.
Mitigation
Ensure clear documentation of symptom absence.